Benitec Biopharma Inc. BNTC Stock
Benitec Biopharma Inc. Price Chart
Benitec Biopharma Inc. BNTC Financial and Trading Overview
| Benitec Biopharma Inc. stock price | 10.4 USD |
| Previous Close | 11.56 USD |
| Open | 11.32 USD |
| Bid | 8.13 USD x 200 |
| Ask | 14.01 USD x 200 |
| Day's Range | 10.82 - 11.66 USD |
| 52 Week Range | 9.85 - 17.15 USD |
| Volume | 81.72K USD |
| Avg. Volume | 137.89K USD |
| Market Cap | 371.71M USD |
| Beta (5Y Monthly) | 0.283 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.93 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 24.33 USD |
BNTC Valuation Measures
| Enterprise Value | 213.25M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.1486199 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.0273561 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -4.582 |
Trading Information
Benitec Biopharma Inc. Stock Price History
| Beta (5Y Monthly) | 0.283 |
| 52-Week Change | -25.94% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 17.15 USD |
| 52 Week Low | 9.85 USD |
| 50-Day Moving Average | 11.77 USD |
| 200-Day Moving Average | 12.7 USD |
BNTC Share Statistics
| Avg. Volume (3 month) | 137.89K USD |
| Avg. Daily Volume (10-Days) | 79.3K USD |
| Shares Outstanding | 34.35M |
| Float | 17.87M |
| Short Ratio | 21.04 |
| % Held by Insiders | 2.69% |
| % Held by Institutions | 98.25% |
| Shares Short | 2.25M |
| Short % of Float | 11.60% |
| Short % of Shares Outstanding | 6.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:17 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -19.93% |
| Return on Equity (ttm) | -29.57% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -46541000 USD |
| Net Income Avi to Common (ttm) | -41542000 USD |
| Diluted EPS (ttm) | -0.93 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 184.76M USD |
| Total Cash Per Share (mrq) | 5.38 USD |
| Total Debt (mrq) | 876K USD |
| Total Debt/Equity (mrq) | 0.48 USD |
| Current Ratio (mrq) | 56.816 |
| Book Value Per Share (mrq) | 5.337 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19792000 USD |
| Levered Free Cash Flow (ttm) | -7130500 USD |
Profile of Benitec Biopharma Inc.
| Country | United States |
| State | CA |
| City | Hayward |
| Address | 3940 Trust Way |
| ZIP | 94545 |
| Phone | 510 780 0819 |
| Website | https://benitec.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 19 |
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Q&A For Benitec Biopharma Inc. Stock
What is a current BNTC stock price?
Benitec Biopharma Inc. BNTC stock price today per share is 10.4 USD.
How to purchase Benitec Biopharma Inc. stock?
You can buy BNTC shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Benitec Biopharma Inc.?
The stock symbol or ticker of Benitec Biopharma Inc. is BNTC.
Which industry does the Benitec Biopharma Inc. company belong to?
The Benitec Biopharma Inc. industry is Biotechnology.
How many shares does Benitec Biopharma Inc. have in circulation?
The max supply of Benitec Biopharma Inc. shares is 34.35M.
What is Benitec Biopharma Inc. Price to Earnings Ratio (PE Ratio)?
Benitec Biopharma Inc. PE Ratio is now.
What was Benitec Biopharma Inc. earnings per share over the trailing 12 months (TTM)?
Benitec Biopharma Inc. EPS is -0.93 USD over the trailing 12 months.
Which sector does the Benitec Biopharma Inc. company belong to?
The Benitec Biopharma Inc. sector is Healthcare.
Benitec Biopharma Inc. BNTC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
| US Tech Composite Total Return XCMP | 33104.2 USD — |
-0.89
|
— — | 32999.64 USD — | 33445.55 USD — | — - | — — |
- {{ link.label }} {{link}}